Arimidex Pharmaqo

£74.00

Anastrozole (Arimidex) is a non-steroidal aromatase inhibitor used extensively in laboratory research to examine estrogen biosynthesis pathways and hormonal regulation mechanisms in cellular and tissue models.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Arimidex Pharmaqo
Arimidex Pharmaqo
£74.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Arimidex Pharmaqo: Compound Profile

Anastrozole is a non-steroidal aromatase inhibitor that serves as a fundamental research tool for investigating estrogen biosynthesis pathways in laboratory settings. As a competitive inhibitor of the aromatase enzyme (CYP19A1), this compound enables researchers at Stroid UK Shop to study hormonal regulation mechanisms with precision. The compound’s pharmaceutical-grade formulation provides consistent results across multiple experimental protocols, making it an essential component for endocrinology and biochemistry research programs.

Laboratory Applications

Research scientists utilise anastrozole to examine the role of estrogen synthesis in various biological processes through controlled in-vitro studies. The compound’s mechanism involves binding to the aromatase enzyme active site, effectively blocking the conversion of androgens to estrogens in cellular models. This specific inhibition allows researchers to evaluate downstream effects on hormone-dependent pathways and receptor interactions. Studies investigating metabolic processes, bone mineralisation pathways, and cellular proliferation mechanisms frequently incorporate anastrozole as a research variable. Laboratories specialising in aromatase inhibitor research often compare anastrozole’s effects with other compounds to establish comprehensive understanding of estrogen pathway modulation. The compound’s oral bioavailability characteristics also make it valuable for pharmacokinetic research models.

Technical Specifications

Anastrozole Research Compound Specifications
Parameter Value
CAS Number 120511-73-1
Molecular Formula C₁₇H₁₉N₅
Molecular Weight 293.37 g/mol
Classification Non-steroidal aromatase inhibitor
Mechanism Competitive CYP19A1 enzyme inhibition
Storage Room temperature, dry environment

Research institutions examining hormone-dependent cellular processes often integrate anastrozole studies with selective androgen receptor modulators and peptide compounds to create comprehensive experimental designs. This multi-compound approach enables researchers to investigate complex hormonal interactions and regulatory networks within controlled laboratory environments.

Research Compliance

This product is manufactured exclusively for in-vitro research applications and is not intended for human consumption or therapeutic use. Researchers must ensure proper laboratory protocols and safety measures when handling this compound in experimental settings.

Related